Macaques #12N010 (left) and #JFL (right) were injected twice SC with 5mg/kg PGT121 eight weeks apart and challenged with SHIV SF162P3 24 hr after the first PGT121 injection and one hr before the second PGT121 injection. Sera collected for 2–3 weeks following each challenge was tested for binding against PGT121 (produced in both plants and CHO), 10–1074 (CHO), VRC01 (CHO) and 3BNC117 (plant).</p
The identification of highly potent broadly neutralizing antibodies (bnAbs) against HIV-1, and succe...
<p>ELISA was used to test the level of gp120-specific antibodies in the plasma of infected rhesus ma...
Simian-human immunodeficiency virus (SHIV) infection provides a relevant animal model to study HIV-1...
Two monkeys were each injected twice with PGT121-YTE (arrows) and bled at the times indicated. Sera ...
Macaques #T769 (blue bars) and # T770 (red bars) from Fig 3 were injected SC with 5mg/kg of PGT121-Y...
Broadly neutralising antibodies (bNAbs) may play an important role in future strategies for HIV cont...
The coloured bars depict binding ADA at OD450 (left axis) at different times after challenge. Black ...
Four macaques received 5mg/kg of PGT121-YTE SC. Two macaques #T766 (dark green) and #13D036 (light g...
Recombinant antibodies play increasingly important roles as immunotherapeutic treatments for human c...
Four macaques received a SC injection of 5mg/kg and were bled and assayed for circulating PGT121-YTE...
<p>(A) Plasma samples from the 11 macaques injected (color coded) were collected 2–3 weeks following...
Two macaques #T769 (blue), T770 (red) received two 5mg/kg injections SC six weeks apart (arrows). An...
AbstractThe simian human immunodeficiency virus (SHIV) macaque model of AIDS has provided a very use...
ObjectivePassive administration of broadly neutralizing antibodies has been shown to protect against...
Protection from immunodeficiency virus challenge in nonhuman primates (NHPs) by a first-generation H...
The identification of highly potent broadly neutralizing antibodies (bnAbs) against HIV-1, and succe...
<p>ELISA was used to test the level of gp120-specific antibodies in the plasma of infected rhesus ma...
Simian-human immunodeficiency virus (SHIV) infection provides a relevant animal model to study HIV-1...
Two monkeys were each injected twice with PGT121-YTE (arrows) and bled at the times indicated. Sera ...
Macaques #T769 (blue bars) and # T770 (red bars) from Fig 3 were injected SC with 5mg/kg of PGT121-Y...
Broadly neutralising antibodies (bNAbs) may play an important role in future strategies for HIV cont...
The coloured bars depict binding ADA at OD450 (left axis) at different times after challenge. Black ...
Four macaques received 5mg/kg of PGT121-YTE SC. Two macaques #T766 (dark green) and #13D036 (light g...
Recombinant antibodies play increasingly important roles as immunotherapeutic treatments for human c...
Four macaques received a SC injection of 5mg/kg and were bled and assayed for circulating PGT121-YTE...
<p>(A) Plasma samples from the 11 macaques injected (color coded) were collected 2–3 weeks following...
Two macaques #T769 (blue), T770 (red) received two 5mg/kg injections SC six weeks apart (arrows). An...
AbstractThe simian human immunodeficiency virus (SHIV) macaque model of AIDS has provided a very use...
ObjectivePassive administration of broadly neutralizing antibodies has been shown to protect against...
Protection from immunodeficiency virus challenge in nonhuman primates (NHPs) by a first-generation H...
The identification of highly potent broadly neutralizing antibodies (bnAbs) against HIV-1, and succe...
<p>ELISA was used to test the level of gp120-specific antibodies in the plasma of infected rhesus ma...
Simian-human immunodeficiency virus (SHIV) infection provides a relevant animal model to study HIV-1...